Ara
Toplam kayıt 5, listelenen: 1-5
Starting Of Biological Disease Modifying Antirheumatic Drugs May Be Postponed In Rheumatoid Arthritis Patients With Multimorbidity
(2018)
The objective of this study was to assess the frequency of comorbidities and multimorbidities in rheumatoid arthritis (RA) patients under biologic therapy and their effects on biological disease modifying antirheumatic ...
Tuberculosis And Viral Hepatitis Infection In Eastern Europe, Asia, And Latin America: Impact Of Tumor Necrosis Factor-Α Inhibitors In Clinical Practice
(2018)
Tumor necrosis factor-α (TNF-α) inhibitors are increasingly becoming the standard of care for treating a number of inflammatory diseases. However, treatment with TNF-α inhibitors carries an inherent risk of compromising ...
Rituximab Therapy in Renal Amyloidosis Secondary To Rheumatoid Arthritis
(2018)
Secondary amyloid A (AA) amyloidosis is a late and serious complication of poorly controlled, chronic inflammatory diseases. Rheumatoid arthritis (RA) patients with poorly controlled, longstanding disease and those with ...
Increased Psoriasis Frequency In Patients With Familial Mediterranean Fever
(2018)
Objective Familial Mediterranean fever (FMF) is a periodic fever syndrome caused by MEFV mutations. FMF may be associated with psoriasis in some cases. The prevalence of psoriasis in the normal Turkish population is 0.42%. ...
What Does Evidence-Based Medicine Tell Us About Treatments For Different Subtypes Of Psoriatic Arthritis? A Systematic Literature Review On Randomized Controlled Trials
(2018)
Objective PsA is a heterogeneous disease with various subtypes of joint manifestations, which can affect the homogeneity of randomized controlled trials (RCTs). The aim of this systematic literature review was to evaluate ...